🔗 Shared analysis
All filings for Raama Finance Ltd →
Raama Finance Discloses Q1 FY27 PAT of ₹4.35 Cr on ₹21.31 Cr Revenue in Investor Deck
Raama Finance released its investor presentation detailing a pivot into digital salaried lending via its 'FastSalary' app. For Q1 FY27, total income surged 120% quarter-on-quarter to ₹21.31 Cr (₹2,130.75 Lakhs), exceeding the entire FY26 revenue of ₹12.13 Cr. Net profit for Q1 FY27 stood at ₹4.35 Cr (up 66% QoQ from ₹2.63 Cr in Q4 FY26), driven by loan disbursals of over ₹43 Cr. The company highlights an average ticket size of ₹45,000 with 70% repeat monthly usage across 6,700+ pin codes.
Confidence: HIGH
What changedRaama Finance published an updated investor presentation revealing rapid operational scale and Q1 FY27 financial figures under its digital lending brand FastSalary.
Why it mattersThe company has transitioned from a dormant entity to a fast-scaling digital NBFC, with single-quarter Q1 FY27 revenue (₹21.31 Cr) far surpassing full-year FY26 revenue (₹12.13 Cr).
Q1 FY27 Total Income: ₹21.31 CrQ1 FY27 Net Profit: ₹4.35 CrQ1 FY27 Disbursals: ₹43 Cr+Q1 FY27 Revenue vs FY26 Annual Revenue: 175.6%
📅 Short termThe strong sequential operational metrics and profitable scaling shared ahead of the Bharat Connect Conference on September 28, 2026, provide positive operational visibility.
📈 Long termStructural expansion depends on maintaining underwriting discipline, controlling credit costs in 30-60 day unsecured loans, and navigating evolving RBI digital lending regulations.
⚠ Risk flags
- Unsecured short-term lending exposure carries inherent default and credit cycle risks
- High sequential growth off a very small historical base makes performance volatile
- Regulatory compliance scrutiny under RBI's digital lending and interest rate framework
Key Highlights
Q1 FY27 total income reached ₹21.31 Cr, up 120% QoQ vs ₹9.69 Cr in Q4 FY26
Q1 FY27 PAT rose to ₹4.35 Cr vs ₹2.63 Cr in Q4 FY26 and ₹0.07 Lakhs in Q1 FY26
Total loan disbursals exceeded ₹43 Cr in Q1 FY27 across 10,373 processed loan applications
Average loan ticket size stood at ₹45,000 with tenors of 30–60 days and a 70% repeat usage rate
👀 What to Watch
Track whether this exponential loan disbursal growth is sustained in upcoming quarterly financial filings and watch asset quality/NPA trends in short-tenor unsecured digital lending.
📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-14 18:53
347 analysed today
FollowTelegram
347
Today
150,786
All-time analysed
43,180
Positive
6,704
Negative
92,129
Neutral
8,705
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1,000+ announcements match the current filters (relevance ≥ 5).
SMC Global Board Approves ₹106 Cr Fundraise via Convertible Warrants to Non-Promoters
SMC Global Securities has approved the issuance of up to 1,00,00,000 fully convertible warrants at ₹106 per warrant to non-promoter investors, aggregating up to ₹106 crore. The proposed issue price represents an 8% discount to the current market price of ₹115.20. The warrants are convertible into equity shares of ₹2 face value within 18 months from allotment. Shareholder approval will be sought at an Extraordinary General Meeting (EGM) on November 6, 2026.
Confidence: HIGH
What changedSMC Global approved raising up to ₹106 crore via preferential issuance of 1 crore convertible warrants to non-promoter entities.
Why it mattersThe fundraise represents ~4.4% of current market cap and ~10.4% of net worth, infusing fresh growth capital into the business while causing mild equity dilution upon conversion.
Total fundraise amount: Rs. 1,06,00,00,000/-Issue price per warrant: Rs. 106/-Number of warrants: 1,00,00,000Fundraise vs Market Cap: ~4.37%Fundraise vs Net Worth: ~10.41%
📅 Short termMarket may react to the ₹106 issue price, which is slightly below the current trading price of ₹115.20. Focus shifts to shareholder voting at the Nov 6 EGM.
📈 Long termThe capital strengthens the balance sheet and could support expansion in NBFC financing or insurance distribution, though conversion will dilute existing equity by approximately 4.5%.
⚠ Risk flags
- Equity dilution of ~4.5% upon full conversion of warrants
- Subject to shareholder approval at the upcoming EGM and regulatory clearances
- 18-month conversion window means full cash infusion is staggered
Key Highlights
Board approved issuance of up to 1,00,00,000 convertible warrants at ₹106 each, raising up to ₹106 crore
Allottees are non-promoters: Mahesh Kumar (42 lakh), SGS Fintech (33 lakh), and Open Advanced Tech (25 lakh)
Warrants convertible into equity shares within a maximum period of 18 months
EGM scheduled on November 6, 2026, to seek shareholder approval for the issue
👀 What to Watch
Track the outcome of the EGM on November 6, 2026, and subsequent allotment disclosures to confirm warrant subscription and upfront cash inflow.
SMC Global Board Approves ₹106 Cr Fundraise via Convertible Warrants to Non-Promoters
SMC Global Securities has approved the issuance of up to 1,00,00,000 fully convertible warrants at ₹106 per warrant to non-promoter investors, aggregating up to ₹106 crore. The proposed issue price represents an 8% discount to the current market price of ₹115.20. The warrants are convertible into equity shares of ₹2 face value within 18 months from allotment. Shareholder approval will be sought at an Extraordinary General Meeting (EGM) on November 6, 2026.
Confidence: HIGH
What changedSMC Global approved raising up to ₹106 crore via preferential issuance of 1 crore convertible warrants to non-promoter entities.
Why it mattersThe fundraise represents ~4.4% of current market cap and ~10.4% of net worth, infusing fresh growth capital into the business while causing mild equity dilution upon conversion.
Total fundraise amount: Rs. 1,06,00,00,000/-Issue price per warrant: Rs. 106/-Number of warrants: 1,00,00,000Fundraise vs Market Cap: ~4.37%Fundraise vs Net Worth: ~10.41%
📅 Short termMarket may react to the ₹106 issue price, which is slightly below the current trading price of ₹115.20. Focus shifts to shareholder voting at the Nov 6 EGM.
📈 Long termThe capital strengthens the balance sheet and could support expansion in NBFC financing or insurance distribution, though conversion will dilute existing equity by approximately 4.5%.
⚠ Risk flags
- Equity dilution of ~4.5% upon full conversion of warrants
- Subject to shareholder approval at the upcoming EGM and regulatory clearances
- 18-month conversion window means full cash infusion is staggered
Key Highlights
Board approved issuance of up to 1,00,00,000 convertible warrants at ₹106 each, raising up to ₹106 crore
Allottees are non-promoters: Mahesh Kumar (42 lakh), SGS Fintech (33 lakh), and Open Advanced Tech (25 lakh)
Warrants convertible into equity shares within a maximum period of 18 months
EGM scheduled on November 6, 2026, to seek shareholder approval for the issue
👀 What to Watch
Track the outcome of the EGM on November 6, 2026, and subsequent allotment disclosures to confirm warrant subscription and upfront cash inflow.
Anupam Rasayan Takes Control of Bliss GVS Pharma; Promoters Reclassified
Bliss GVS Pharma confirmed that Anupam Rasayan India Limited and Mates Visa Consultancy Private Limited have acquired control of the company following an open offer and a Share Purchase Agreement dated May 23, 2026. The transaction was consummated on September 28, 2026, leading to the reclassification of erstwhile promoters to the public category. Anupam Rasayan and its 13 affiliated entities now form the new promoter and promoter group. This completes a formal change of ownership and management control for the Rs 7,298 crore market cap company.
Confidence: HIGH
What changedFormal transfer of control of Bliss GVS Pharma to Anupam Rasayan India Ltd and Mates Visa Consultancy Pvt Ltd, with erstwhile promoters moving to the public category.
Why it mattersRepresents a complete ownership transition to a major specialty chemical player, potentially unlocking synergies in API integration, global reach, and corporate governance.
SPA Execution Date: May 23, 2026Transaction Consummation Date: September 28, 2026New Promoter Entities Listed: 15Market Capitalization Context: Rs 7298 Cr
📅 Short termMarket may react positively to the clear resolution and formalization of the control shift to Anupam Rasayan.
📈 Long termStructural changes under the new promoter could accelerate Bliss GVS's expansion into regulated markets and enhance manufacturing efficiencies.
⚠ Risk flags
- Integration risks between specialty chemical and pharmaceutical formulations businesses
- High export exposure (93% of revenue) mainly concentrated in African markets
Key Highlights
Anupam Rasayan India Ltd and Mates Visa Consultancy Pvt Ltd formally acquired control on September 28, 2026
Consummation follows the Share Purchase Agreement executed on May 23, 2026, alongside an open offer
Erstwhile promoters reclassified to public category under SEBI Regulation 31A(10)
New promoter group includes 15 entities, featuring Tanfac Industries Limited and ARIL subsidiaries
👀 What to Watch
Monitor upcoming quarterly filings and investor presentations for post-acquisition strategic directions, board reconstitutions, and operational synergies with Anupam Rasayan.
Brooks Labs Approves Demerger of Manufacturing Business into Abridge Speciality in 1:1 Ratio
Brooks Laboratories has approved a Scheme of Arrangement to demerge its Baddi manufacturing business into its wholly-owned subsidiary, Abridge Speciality Limited. The demerged undertaking accounted for Rs 82.87 crore (96.66%) of the company's FY26 total turnover. Under the scheme, shareholders will receive 1 share of Abridge Speciality for every 1 share held in Brooks Laboratories, with listing intended for the resulting entity on BSE and NSE. The residual business will focus on trading and be renamed Xuri Lifesciences, while Abridge Speciality will adopt the Brooks Laboratories name.
Confidence: HIGH
What changedBoard approved demerging the core Baddi manufacturing operations into wholly-owned subsidiary Abridge Speciality Limited via a 1:1 vertical split.
Why it mattersSeparates the manufacturing unit (96.66% of FY26 revenue) from the trading business to facilitate independent management, targeted capital allocation, and aligned promoter ownership.
Demerged Unit FY26 Turnover: Rs. 8,287.26 lakhsShare of Demerged Turnover in Total: 96.66%Share Entitlement Ratio: 1:1Shares to be Allotted by Resulting Co: 2,94,57,248Indicative Timeline to Listing: About 16 months
📅 Short termMarket may view the 1:1 demerger positively due to clear segregation of core manufacturing, though price action may be balanced by the lengthy execution timeline.
📈 Long termCreates two distinct listed entities; unlocks potential value if the demerged manufacturing entity scales and achieves independent financing and operational focus.
⚠ Risk flags
- Lengthy restructuring timeline (~16 months) requiring NCLT, SEBI, exchange, and creditor approvals
- Demerged entity takes 96.66% of revenue, leaving the residual company with a very small initial turnover base
Key Highlights
Demerged business accounted for Rs 82.87 crore or 96.66% of FY26 total turnover
Share entitlement ratio approved at 1:1 (one share of Abridge Speciality for each share of Brooks Labs)
Abridge Speciality will issue 2,94,57,248 equity shares and seek listing on BSE and NSE
Estimated timeline to final listing is approximately 16 months across 4 stages
Expected capital availability of ~Rs 50 crore planned for strategic growth in each platform
👀 What to Watch
Track the regulatory progress over the next 6 months, specifically stock exchange approvals and the filing of the first-motion petition before the NCLT.
MVK Agro approves private placement of NCDs up to Rs 75 Cr
M.V.K. Agro Food Product's Board of Directors approved the issuance of up to 7,500 secured, listed, rated, redeemable Non-Convertible Debentures (NCDs) aggregating up to Rs 75 crore on a private placement basis. The NCDs carry a face value of Rs 1,00,000 each and will have a tenure of up to 30 months, proposed to be listed on BSE Limited. The fundraise is material, representing approximately 33.9% of existing debt (Rs 221 Cr) and 25.7% of TTM revenue (Rs 292 Cr). Coupon rate, pricing, and charge creation details will be finalised in due course by the newly constituted Debenture Issue and Allotment Committee.
Confidence: HIGH
What changedThe board approved a fresh borrowing programme of up to Rs 75 crore via secured rated NCDs on private placement.
Why it mattersAdds substantial debt to the balance sheet (~34% increase over current Rs 221 Cr debt), likely financing ongoing sugar and ethanol capacity expansions, but increasing interest cost obligations.
Total issue size: Rs. 75,00,00,000Number of NCDs: Up to 7,500Face value per NCD: Rs. 1,00,000Tenure: Up to 30 monthsIssue size vs TTM Debt: ~33.9%Issue size vs TTM Revenue: ~25.7%
📅 Short termMarket attention will focus on the finalized coupon rate and investor participation terms once determined by the committee.
📈 Long termDepending on effective capital deployment into ethanol and crushing capacity expansion, higher leverage may pressure balance sheet health if operational cash flows do not ramp up as anticipated.
⚠ Risk flags
- Increases balance sheet leverage (existing debt Rs 221 Cr against Net Worth Rs 413 Cr)
- Interest rate/coupon terms not yet finalized
- Short maturity tenure of up to 30 months requiring refinancing or strong cash flow generation
Key Highlights
Approved issue of up to 7,500 NCDs of face value Rs 1,00,000 each aggregating up to Rs 75 crore
Issued via private placement in one or more tranches with tenure up to 30 months
Proposed to be listed on BSE Limited
Appointed Mitcon Credentia Trusteeship Services Limited as the Debenture Trustee
👀 What to Watch
Track the upcoming disclosures regarding the coupon rate, security pledged, and specific deployment timeline of the Rs 75 crore proceeds across ongoing capacity expansions.
Jio Platforms Files RHP for 27 Cr Share Fresh Issue IPO; Opens Oct 21, 2026
Reliance Industries subsidiary Jio Platforms Limited (JPL) has filed its Red Herring Prospectus (RHP) with the RoC Gujarat for an Initial Public Offering comprising a fresh issue of up to 27,00,00,000 equity shares (face value Rs. 10 each). The issue reserves up to Rs. 2,500 crore for eligible RIL public shareholders and up to Rs. 500 crore for eligible employees. Anchor bidding opens on October 19, 2026, while public subscription runs from October 21 to October 23, 2026.
Confidence: HIGH
What changedJio Platforms Limited has officially filed its RHP, confirming IPO timelines and issue reservations.
Why it mattersMarks the formal timeline for the mega-listing of RIL's digital and telecom arm, aiding value unlocking for the parent company.
Fresh issue shares: 27,00,00,000RIL shareholder reservation: Rs. 2,500 croreEmployee reservation: Rs. 500 croreFace value per share: Rs. 10
📅 Short termMarket attention will focus on the impending price band announcement and bidding response between October 19 and October 23, 2026.
📈 Long termProvides market price discovery and direct capitalization for JPL's digital and 5G infrastructure, reinforcing RIL's broader conglomerate restructuring.
⚠ Risk flags
- Market volatility impacting IPO subscription and eventual listing valuation
- Final pricing band yet to be disclosed
Key Highlights
Fresh issue size of up to 27,00,00,000 equity shares of face value Rs. 10 each
Reservation of up to Rs. 2,500 crore for eligible RIL public shareholders as of October 14, 2026
Employee reservation portion of up to Rs. 500 crore
Public subscription dates set for October 21 to October 23, 2026 (Anchor bidding: October 19, 2026)
👀 What to Watch
Track the announcement of the IPO price band and valuation metrics ahead of the anchor bid date on October 19, 2026, to assess value unlocking for RIL.
CEAT Q2 Consolidated Revenue Up 26% YoY to Rs 4,762 Cr; EBITDA Margin at 9.5%
CEAT reported Q2 FY26-27 consolidated revenue of Rs 4,762 crore, marking a 26% YoY increase driven by growth in premium segments. Consolidated net profit came in at Rs 112 crore, while EBITDA margin stood at 9.5% amid high raw material costs fueled by the West Asia conflict. Standalone net profit reached Rs 164 crore on revenue of Rs 4,548 crore (up 23% YoY). The company invested close to Rs 490 crore in capex during the quarter (~3% of TTM revenue) to expand high-utilization capacities and appointed Mr. Sumeet Narang as an Independent Director.
Confidence: HIGH
What changedCEAT declared its Q2 FY26-27 unaudited financial results and approved the appointment of Mr. Sumeet Narang as Non-Executive Independent Director for 5 years.
Why it mattersDemonstrates robust top-line momentum via premiumization and CAMSO inclusion, though ongoing commodity headwinds are compressing operating margins to single digits.
Consolidated Revenue: Rs 4,762 croreConsolidated Net Profit: Rs 112 croreConsolidated EBITDA Margin: 9.5%Quarterly Capex: close to Rs 490 croreQuarter Capex vs TTM Revenue: ~3.0%
📅 Short termMargins will likely face sustained pressure in Q3 as commodity costs remain elevated, but price hikes in H2 may partially mitigate this impact.
📈 Long termIntegration of the Camso business and premiumization across passenger car and 2-wheeler tyres support capacity absorption, though elevated debt from ongoing capex bears watching.
⚠ Risk flags
- Elevated raw material costs linked to geopolitical tensions in West Asia
- Increased debt levels driven by continuous capex of ~Rs 490 crore and dividend payouts
Key Highlights
Consolidated revenue up 26% YoY to Rs 4,762 crore in Q2
Consolidated net profit stood at Rs 112 crore with an EBITDA margin of 9.5%
Standalone revenue increased 23% YoY to Rs 4,548 crore with net profit of Rs 164 crore
Quarterly capex deployed at close to Rs 490 crore to expand capacities, driving up debt
Converted $24.5 million loan to Ceat OHT Lanka into Rs 234 crore equity
👀 What to Watch
Monitor commodity price trends and the management's planned calibrated price hikes in H2 to offset persistent input cost inflation.
Gujarat Energy Pays Record ₹324 Cr FY26 Dividend to Gujarat Govt Following Group Restructuring
Gujarat Energy Limited (formerly Gujarat Gas Limited) announced a record dividend payment of ₹324 Crores to the Government of Gujarat for FY 2025-26 at ₹8.90 per share on 36.40 crore shares. This follows the Scheme of Arrangement effective May 1, 2026, which amalgamated GSPC into Gujarat Gas and increased the State Government's holding from ~6% to ~38%. Together with GSPL Transmission Limited's payout of ₹60.67 Crores, total payouts to the state reached ₹384.67 Crores. In comparison, prior cumulative payouts over FY23-FY25 totaled ₹81.55 Crores.
Confidence: HIGH
What changedFormal handover of dividend cheques for FY26 totaling ₹324 Crores to the Government of Gujarat following the completion and implementation of the GSPC group corporate restructuring.
Why it mattersDemonstrates the cash return profile of the restructured entity and confirms the substantial increase in the Government of Gujarat's direct ownership to ~38%.
Dividend to Govt of Gujarat (FY26): Rs. 324 CroresDividend Per Share (FY26): Rs. 8.90Government Shareholding Post-Scheme: about 38%GEL FY26 Dividend vs FY26 PAT: ~26.0%
📅 Short termLargely informational PR documenting the formal handover of dividend payments previously declared under the approved Scheme of Arrangement; minimal immediate price impact expected.
📈 Long termReflects the post-merger structure of Gujarat Energy as a primary integrated energy PSU entity for Gujarat, with an ongoing emphasis on state treasury returns.
⚠ Risk flags
- High dividend payout commitments could constrain internal cash generation for capital expenditure.
Key Highlights
Paid record ₹324 Crores in FY26 dividend to Government of Gujarat at ₹8.90 per share.
State Government holding in Gujarat Energy increased from ~6% pre-scheme to ~38% post-scheme.
Scheme of Amalgamation & Arrangement of GSPC Group came into effect from May 1, 2026.
Combined FY26 dividend by GEL and GSPL Transmission Limited to the Government totaled ₹384.67 Crores.
Prior 3-year cumulative dividend paid to the Government (FY23–FY25) stood at ~₹81.55 Crores.
👀 What to Watch
Track subsequent quarterly earnings to monitor post-merger integration efficiencies and cash flow generation supporting these higher corporate dividend levels.
CEAT Q2 Consolidated Revenue Up 26% YoY to Rs 4,762 Cr; EBITDA Margin at 9.5%
CEAT reported Q2 FY26-27 consolidated revenue of Rs 4,762 crore, marking a 26% YoY increase driven by growth in premium segments. Consolidated net profit came in at Rs 112 crore, while EBITDA margin stood at 9.5% amid high raw material costs fueled by the West Asia conflict. Standalone net profit reached Rs 164 crore on revenue of Rs 4,548 crore (up 23% YoY). The company invested close to Rs 490 crore in capex during the quarter (~3% of TTM revenue) to expand high-utilization capacities and appointed Mr. Sumeet Narang as an Independent Director.
Confidence: HIGH
What changedCEAT declared its Q2 FY26-27 unaudited financial results and approved the appointment of Mr. Sumeet Narang as Non-Executive Independent Director for 5 years.
Why it mattersDemonstrates robust top-line momentum via premiumization and CAMSO inclusion, though ongoing commodity headwinds are compressing operating margins to single digits.
Consolidated Revenue: Rs 4,762 croreConsolidated Net Profit: Rs 112 croreConsolidated EBITDA Margin: 9.5%Quarterly Capex: close to Rs 490 croreQuarter Capex vs TTM Revenue: ~3.0%
📅 Short termMargins will likely face sustained pressure in Q3 as commodity costs remain elevated, but price hikes in H2 may partially mitigate this impact.
📈 Long termIntegration of the Camso business and premiumization across passenger car and 2-wheeler tyres support capacity absorption, though elevated debt from ongoing capex bears watching.
⚠ Risk flags
- Elevated raw material costs linked to geopolitical tensions in West Asia
- Increased debt levels driven by continuous capex of ~Rs 490 crore and dividend payouts
Key Highlights
Consolidated revenue up 26% YoY to Rs 4,762 crore in Q2
Consolidated net profit stood at Rs 112 crore with an EBITDA margin of 9.5%
Standalone revenue increased 23% YoY to Rs 4,548 crore with net profit of Rs 164 crore
Quarterly capex deployed at close to Rs 490 crore to expand capacities, driving up debt
Converted $24.5 million loan to Ceat OHT Lanka into Rs 234 crore equity
👀 What to Watch
Monitor commodity price trends and the management's planned calibrated price hikes in H2 to offset persistent input cost inflation.
CEAT Q2 Consolidated Revenue Up 26% YoY to Rs 4,762 Cr; EBITDA Margin at 9.5%
CEAT reported Q2 FY26-27 consolidated revenue of Rs 4,762 crore, marking a 26% YoY increase driven by growth in premium segments. Consolidated net profit came in at Rs 112 crore, while EBITDA margin stood at 9.5% amid high raw material costs fueled by the West Asia conflict. Standalone net profit reached Rs 164 crore on revenue of Rs 4,548 crore (up 23% YoY). The company invested close to Rs 490 crore in capex during the quarter (~3% of TTM revenue) to expand high-utilization capacities and appointed Mr. Sumeet Narang as an Independent Director.
Confidence: HIGH
What changedCEAT declared its Q2 FY26-27 unaudited financial results and approved the appointment of Mr. Sumeet Narang as Non-Executive Independent Director for 5 years.
Why it mattersDemonstrates robust top-line momentum via premiumization and CAMSO inclusion, though ongoing commodity headwinds are compressing operating margins to single digits.
Consolidated Revenue: Rs 4,762 croreConsolidated Net Profit: Rs 112 croreConsolidated EBITDA Margin: 9.5%Quarterly Capex: close to Rs 490 croreQuarter Capex vs TTM Revenue: ~3.0%
📅 Short termMargins will likely face sustained pressure in Q3 as commodity costs remain elevated, but price hikes in H2 may partially mitigate this impact.
📈 Long termIntegration of the Camso business and premiumization across passenger car and 2-wheeler tyres support capacity absorption, though elevated debt from ongoing capex bears watching.
⚠ Risk flags
- Elevated raw material costs linked to geopolitical tensions in West Asia
- Increased debt levels driven by continuous capex of ~Rs 490 crore and dividend payouts
Key Highlights
Consolidated revenue up 26% YoY to Rs 4,762 crore in Q2
Consolidated net profit stood at Rs 112 crore with an EBITDA margin of 9.5%
Standalone revenue increased 23% YoY to Rs 4,548 crore with net profit of Rs 164 crore
Quarterly capex deployed at close to Rs 490 crore to expand capacities, driving up debt
Converted $24.5 million loan to Ceat OHT Lanka into Rs 234 crore equity
👀 What to Watch
Monitor commodity price trends and the management's planned calibrated price hikes in H2 to offset persistent input cost inflation.
CEAT Q2 Consolidated Revenue Up 26% YoY to Rs 4,762 Cr; EBITDA Margin at 9.5%
CEAT reported Q2 FY26-27 consolidated revenue of Rs 4,762 crore, marking a 26% YoY increase driven by growth in premium segments. Consolidated net profit came in at Rs 112 crore, while EBITDA margin stood at 9.5% amid high raw material costs fueled by the West Asia conflict. Standalone net profit reached Rs 164 crore on revenue of Rs 4,548 crore (up 23% YoY). The company invested close to Rs 490 crore in capex during the quarter (~3% of TTM revenue) to expand high-utilization capacities and appointed Mr. Sumeet Narang as an Independent Director.
Confidence: HIGH
What changedCEAT declared its Q2 FY26-27 unaudited financial results and approved the appointment of Mr. Sumeet Narang as Non-Executive Independent Director for 5 years.
Why it mattersDemonstrates robust top-line momentum via premiumization and CAMSO inclusion, though ongoing commodity headwinds are compressing operating margins to single digits.
Consolidated Revenue: Rs 4,762 croreConsolidated Net Profit: Rs 112 croreConsolidated EBITDA Margin: 9.5%Quarterly Capex: close to Rs 490 croreQuarter Capex vs TTM Revenue: ~3.0%
📅 Short termMargins will likely face sustained pressure in Q3 as commodity costs remain elevated, but price hikes in H2 may partially mitigate this impact.
📈 Long termIntegration of the Camso business and premiumization across passenger car and 2-wheeler tyres support capacity absorption, though elevated debt from ongoing capex bears watching.
⚠ Risk flags
- Elevated raw material costs linked to geopolitical tensions in West Asia
- Increased debt levels driven by continuous capex of ~Rs 490 crore and dividend payouts
Key Highlights
Consolidated revenue up 26% YoY to Rs 4,762 crore in Q2
Consolidated net profit stood at Rs 112 crore with an EBITDA margin of 9.5%
Standalone revenue increased 23% YoY to Rs 4,548 crore with net profit of Rs 164 crore
Quarterly capex deployed at close to Rs 490 crore to expand capacities, driving up debt
Converted $24.5 million loan to Ceat OHT Lanka into Rs 234 crore equity
👀 What to Watch
Monitor commodity price trends and the management's planned calibrated price hikes in H2 to offset persistent input cost inflation.
CRISIL Upgrades Piccadily Agro's Bank Debt to 'CRISIL A+/Stable/A1' on Rs 400 Cr Facilities
CRISIL Ratings has assigned and upgraded Piccadily Agro Industries' bank loan facilities of Rs 400 crore to 'CRISIL A+/Stable' for long-term and 'CRISIL A1' for short-term (previously IVR A/Stable and IVR A1 by Infomerics). The agency highlighted strong performance led by its flagship single malt brand 'Indri' and expanded distillery operations, projecting 50-60% revenue growth in FY27. Financial leverage is comfortable with gearing at 0.6x as of March 31, 2026, and interest coverage at 8.6 times in FY26. Total rated bank debt of Rs 400 crore represents approximately 35.2% of its TTM revenue of Rs 1,137 crore.
Confidence: HIGH
What changedCRISIL assigned and upgraded the company's bank loan rating to 'CRISIL A+/Stable/CRISIL A1' from Infomerics' 'IVR A/Stable/IVR A1' for Rs 400 crore bank facilities.
Why it mattersThe rating upgrade lowers borrowing costs, validates the ongoing operational turnaround from sugar to high-margin premium single malt spirits, and confirms a comfortable balance sheet with 0.6x gearing.
Total Bank Loan Facilities Rated: Rs 400 CroreRated debt vs TTM revenue: ~35.2%Projected FY27 Revenue Growth: 50–60%Reported Net Worth (March 2026): Rs 901 croreGearing (March 31, 2026): 0.6 times
📅 Short termPositive sentiment from an established tier-1 agency upgrade validating balance sheet strength and operational cash flow health.
📈 Long termReflects the company's structural shift toward luxury and premium spirits, underpinned by matured malt inventories and scaled distillery capacities that provide durable margin expansion.
⚠ Risk flags
- High working capital intensity driven by inventory aging requirements for single malts.
- Vulnerability to state-level liquor excise regulations and changes in ethanol procurement policies.
Key Highlights
Credit rating upgraded to CRISIL A+/Stable (Long Term) and CRISIL A1 (Short Term) across Rs 400 crore bank facilities.
CRISIL projects revenue growth of 50-60% in FY27 driven by recent capacity expansions and Indri single malt penetration.
Operating margins reached 22.5% in FY26 and are projected at 22-24% in FY27 as distillery revenue share hit 79%.
Gearing stood at ~0.6x as of March 31, 2026, with net worth at Rs 901 crore and interest coverage at 8.6 times.
👀 What to Watch
Track the ramp-up and excise approvals of the expanded Indri malt distillery (30 KLPD) and greenfield Chhattisgarh facility (200 KLPD) alongside working capital efficiency in upcoming quarterly results.
CEAT Q2 Consolidated Revenue Up 26% YoY to Rs 4,762 Cr; EBITDA Margin at 9.5%
CEAT reported Q2 FY26-27 consolidated revenue of Rs 4,762 crore, marking a 26% YoY increase driven by growth in premium segments. Consolidated net profit came in at Rs 112 crore, while EBITDA margin stood at 9.5% amid high raw material costs fueled by the West Asia conflict. Standalone net profit reached Rs 164 crore on revenue of Rs 4,548 crore (up 23% YoY). The company invested close to Rs 490 crore in capex during the quarter (~3% of TTM revenue) to expand high-utilization capacities and appointed Mr. Sumeet Narang as an Independent Director.
Confidence: HIGH
What changedCEAT declared its Q2 FY26-27 unaudited financial results and approved the appointment of Mr. Sumeet Narang as Non-Executive Independent Director for 5 years.
Why it mattersDemonstrates robust top-line momentum via premiumization and CAMSO inclusion, though ongoing commodity headwinds are compressing operating margins to single digits.
Consolidated Revenue: Rs 4,762 croreConsolidated Net Profit: Rs 112 croreConsolidated EBITDA Margin: 9.5%Quarterly Capex: close to Rs 490 croreQuarter Capex vs TTM Revenue: ~3.0%
📅 Short termMargins will likely face sustained pressure in Q3 as commodity costs remain elevated, but price hikes in H2 may partially mitigate this impact.
📈 Long termIntegration of the Camso business and premiumization across passenger car and 2-wheeler tyres support capacity absorption, though elevated debt from ongoing capex bears watching.
⚠ Risk flags
- Elevated raw material costs linked to geopolitical tensions in West Asia
- Increased debt levels driven by continuous capex of ~Rs 490 crore and dividend payouts
Key Highlights
Consolidated revenue up 26% YoY to Rs 4,762 crore in Q2
Consolidated net profit stood at Rs 112 crore with an EBITDA margin of 9.5%
Standalone revenue increased 23% YoY to Rs 4,548 crore with net profit of Rs 164 crore
Quarterly capex deployed at close to Rs 490 crore to expand capacities, driving up debt
Converted $24.5 million loan to Ceat OHT Lanka into Rs 234 crore equity
👀 What to Watch
Monitor commodity price trends and the management's planned calibrated price hikes in H2 to offset persistent input cost inflation.
Himachal HC Quashes Rs 117.94 Cr GST Demand Show Cause Notice Against Morepen Laboratories
The High Court of Himachal Pradesh has quashed a Show Cause Notice (SCN) issued by the Central GST Commissionerate demanding Rs 117.94 crore in excess GST refund along with interest and penalty. The original demand dated December 2, 2025, represented approximately 83.6% of the company's TTM PAT of Rs 141 crore and 9.5% of its net worth (Rs 1,243 crore). With the writ petition disposed in favour of Morepen Laboratories, the company faces no financial liability or operational disruption from this dispute. The order was passed on October 12, 2026, and received by the company on October 14, 2026.
Confidence: HIGH
What changedThe Himachal Pradesh High Court has fully quashed the Rs 117.94 crore GST recovery show cause notice, deciding the matter entirely in favour of Morepen Laboratories.
Why it mattersA potential tax liability representing over 80% of annual net profit has been removed, eliminating a significant balance sheet and cash flow overhang.
Quashed GST demand: ₹117,94,03,452Demand vs TTM PAT: ~83.6%Demand vs Net Worth: ~9.5%Order date: 12th October 2026Receipt date: 14th October 2026
📅 Short termPositive sentiment driver as an overhang of nearly Rs 118 crore in potential tax clawback is eliminated.
📈 Long termStrengthens financial clarity and protects retained earnings, though investors should ensure no further legal appeals are initiated by tax authorities.
⚠ Risk flags
- Possibility of the GST department challenging the High Court judgment in higher courts (Supreme Court)
Key Highlights
Himachal Pradesh High Court quashed the GST Show Cause Notice demanding recovery of Rs 117,94,03,452
Demand amount of Rs 117.94 crore represents ~83.6% of TTM PAT (Rs 141 crore) and ~6% of TTM revenue (Rs 1,951 crore)
Allegations pertained to excess GST refund claims under Section 54 of CGST Act read with Rule 89(4)
Order passed on October 12, 2026, and formally received by the company on October 14, 2026 at 3:00 p.m.
Company confirmed zero financial, operational, or other adverse impact following the court ruling
👀 What to Watch
Track whether the GST Department files an appeal or Special Leave Petition (SLP) before the Supreme Court against the High Court order, and monitor upcoming Q2 FY27 earnings for core operating performance.
Kesar India Allots 17.32 Lakh Shares at Rs 900 via Share Swap Worth Rs 155.86 Cr
Kesar India Limited has approved the preferential allotment of 17,31,752 equity shares of face value Rs 10 each at an issue price of Rs 900 per share, amounting to Rs 155.86 crore. The allotment is executed for consideration other than cash via a share swap to promoters Yash Gopal Gupta and Sangeeta Gopalchand Gupta (8,65,876 shares each). Following this allotment, the company's paid-up equity share capital increases to Rs 34.27 crore across 3.43 crore shares. The total issuance represents approximately 4.7% of the current market capitalization (Rs 3,318 crore) and will increase promoter holding.
Confidence: HIGH
What changedKesar India expanded its share base by 17.32 lakh shares by issuing equity to promoters via a share swap at Rs 900 per share.
Why it mattersThe Rs 155.86 crore transaction consolidates promoter equity into the listed entity via non-cash asset or share acquisition, expanding the equity base by roughly 5.3% of pre-issue capital.
Shares allotted: 17,31,752Issue price per share: Rs 900Total allotment value: Rs 155.86 CrNew paid-up equity capital: Rs 34,26,59,700Allotment value vs Market Cap: ~4.7%
📅 Short termNeutral market impact expected as the issue price of Rs 900 is at a discount to the current market price of Rs 1,157.30, though it involves no direct cash inflow.
📈 Long termDepends on the operational integration and value accretion of the underlying assets or entities brought into the listed entity through this share swap.
⚠ Risk flags
- Related-party transaction involving promoter entities
- Equity dilution of ~5.1% on expanded equity base without cash inflow
Key Highlights
Allotted 17,31,752 equity shares on a preferential basis for consideration other than cash via share swap
Issue price fixed at Rs 900 per equity share (face value Rs 10 each), totaling Rs 155.86 crore
Allottees are promoters Yash Gopal Gupta (8,65,876 shares) and Sangeeta Gopalchand Gupta (8,65,876 shares)
Paid-up equity capital increased to Rs 34,26,59,700 comprising 3,42,65,970 equity shares
👀 What to Watch
Track subsequent shareholding pattern filings to assess the exact post-issue promoter shareholding percentage and any disclosures regarding the swapped entity/assets.
Mphasis faces revised tax demand of ₹2,417.80 Cr following Section 154 rectification order
Mphasis Limited has received a rectification order under Section 154 of the Income-tax Act, 1961 for Assessment Year 2023-24, increasing its tax demand from ₹2,286.86 crore to ₹2,417.80 crore. The ₹130.94 crore increase is attributable to interest levied under Section 220. The total demand represents approximately 37.3% of the company's net worth (₹6,474 crore) and exceeds its annual TTM PAT of ₹1,911 crore. However, Mphasis noted errors in computation, plans to pursue legal remedies and file a rectification petition, and currently expects no material financial statement impact.
Confidence: HIGH
What changedThe Income Tax department revised an earlier assessment demand for AY 2023-24 upward by ₹130.94 crore to ₹2,417.80 crore via a Section 154 rectification order.
Why it mattersThe quantum of the demand is substantial relative to Mphasis's annual profits (126.5% of TTM PAT) and net worth (37.3%), posing a headline dispute risk even though management expects no material financial statement impact.
Revised tax demand: ₹2,417.80 croreOriginal demand: ₹2,286.86 croreAdditional interest levied: ₹130.94 croreDemand vs TTM PAT: ~126.5%Demand vs Net Worth: ~37.3%
📅 Short termMay weigh on sentiment given the large headline figure, though operational impact depends on the timeline of appeals and stay of demand.
📈 Long termIT sector tax disputes frequently undergo prolonged appellate stages (ITAT/High Court) without immediate cash impairment, but sustained adverse rulings could lead to provisioning.
⚠ Risk flags
- High dispute amount relative to net worth (37.3%) and TTM PAT (126.5%)
- Risk of required pre-deposits during the appeal process
Key Highlights
Tax demand revised upward from ₹2,286.86 crore to ₹2,417.80 crore
Increase of ₹130.94 crore due to interest levied under Section 220 of the Income-tax Act
Order issued on October 9, 2026, and received by the company on October 13, 2026
Company intends to file a rectification petition citing computation errors and seek legal remedies
👀 What to Watch
Track subsequent filings regarding the filing of the rectification petition, appellate proceedings, and whether any pre-deposit or cash outflow is mandated during dispute resolution.
NLC India Secures LoA for 50 MW/200 MWh BESS Project in West Bengal
NLC India Limited's wholly owned subsidiary, NLC India Renewables Limited (NIRL), has won a tender from WBSEDCL for setting up a Standalone Battery Energy Storage System (BESS). The contract awards the development of a 50 MW / 200 MWh capacity BESS located at Arambag, Hooghly, West Bengal under tariff-based competitive bidding. While the exact contract value and capital outlay were not disclosed, this win aligns with the company's stated strategic roadmap to expand beyond thermal power into BESS and renewable integration. Against TTM revenue of ₹18,648 Cr, the project represents an incremental operational foray into grid-scale energy storage.
Confidence: HIGH
What changedNLC India's subsidiary NIRL has received a Letter of Award to build and operate a 50 MW/200 MWh standalone battery storage project in West Bengal.
Why it mattersMarks progress on NLC India's strategic push into non-fossil services and grid-scale storage, complementing its long-term plan to reach 10 GW total capacity.
Storage Power Capacity: 50 MWStorage Energy Capacity: 200 MWhContract Value: not disclosed
📅 Short termPositive sentiment from entry into grid-scale storage contracts; financial impact in the near term will depend on disclosed tariffs and capex.
📈 Long termSupports diversification from lignite/coal generation toward modern renewable-enabling infrastructure, enhancing blended ESG and utility-scale capabilities.
⚠ Risk flags
- Counterparty risk associated with state discom (WBSEDCL)
- Execution and battery component supply-chain risks
- Tariff viability and margins not disclosed
Key Highlights
Subsidiary NIRL secured Letter of Award (LoA) for a 50 MW/200 MWh Standalone BESS project
Project location awarded at Arambag, Hooghly, West Bengal via tariff-based competitive bidding
Tender floated by Dept of Power, GoWB on behalf of WBSEDCL
Commercial project value and commissioning timelines were not disclosed in the filing
👀 What to Watch
Track subsequent disclosures regarding total capex commitment, tariff rate per MW/MWh, and commissioning timelines for this BESS installation.
Q2 FY27 Net Profit Rises 64.9% YoY to ₹70.53 Cr; Revenue Up 26% to ₹326.72 Cr
Bajaj Consumer Care reported standalone revenue from operations of ₹326.72 Cr for Q2 FY27, up 25.9% YoY from ₹259.41 Cr in Q2 FY26. Standalone net profit climbed 64.9% YoY to ₹70.53 Cr compared to ₹42.78 Cr in the corresponding prior-year quarter. For H1 FY27, net profit stood at ₹140.69 Cr on revenues of ₹661.83 Cr. Additionally, the Board appointed FMCG veteran Jitendra Mahajan as Independent Director following the resignation of K.S. Narayanan.
Confidence: HIGH
What changedAnnounced Q2 FY27 earnings showing substantial YoY profit and revenue expansion, along with board reconstitution.
Why it mattersDemonstrates robust operating leverage and top-line recovery compared to FY26 base periods, with net profit margins expanding sharply.
Standalone Revenue (Q2 FY27): ₹32,671.94 lakhStandalone PAT (Q2 FY27): ₹7,052.83 lakhStandalone PAT Growth YoY: 64.9%H1 FY27 PAT: ₹14,068.77 lakh
📅 Short termStrong operational print is likely to be viewed favourably by the market in the coming sessions given the 64.9% YoY net profit growth.
📈 Long termSustained execution across non-ADHO portfolio diversification and brand scaling will determine if margins and growth stay elevated.
⚠ Risk flags
- Input cost volatility (crude oil/LLP packaging) could compress gross margins in upcoming quarters
- High dependence on flagship hair oil category
Key Highlights
Standalone revenue from operations reached ₹32,671.94 lakh (₹326.72 Cr), up 25.9% YoY
Net profit surged 64.9% YoY to ₹7,052.83 lakh (₹70.53 Cr) from ₹4,278.05 lakh in Q2 FY26
Profit before tax grew 68% YoY to ₹8,715.80 lakh compared to ₹5,188.76 lakh
Advertising and sales promotion expenses stood at ₹4,073.55 lakh vs ₹3,808.27 lakh in Q2 FY26
Board approved 5-year appointment of Jitendra Ananda Mahajan as Non-Executive Independent Director
👀 What to Watch
Track subsequent quarters to see if the >20% revenue growth trajectory holds amidst raw material price dynamics and ad-spend investments.
Q2 FY27 Net Sales up 27.3% to ₹332.7 Cr; PAT Surges 66.0% to ₹70.2 Cr
Bajaj Consumer Care reported a strong Q2 FY27 performance, with consolidated net sales increasing 27.3% YoY to ₹332.7 crore. EBITDA jumped 71.0% YoY to ₹83.3 crore, expanding operating margins significantly to 25.0% from 18.6% in Q2 FY26. Consolidated Profit After Tax (PAT) grew 66.0% YoY to ₹70.2 crore, aided by 30%+ revenue growth in domestic hair oils and steady gross margin expansion to 59.9%. For H1 FY27, net sales rose 27.8% YoY to ₹674.1 crore, while PAT climbed 74.8% YoY to ₹140.9 crore.
Confidence: HIGH
What changedFiling of the Q2 FY27 investor presentation following the NCLT-approved amalgamation of Vishal Personal Care Limited.
Why it mattersDemonstrates operating leverage with substantial EBITDA margin expansion (+640 bps YoY) and strong volume-led growth across domestic channels.
Q2 FY27 Net Sales: ₹332.7 CrQ2 FY27 EBITDA Margin: 25.0%Q2 FY27 PAT: ₹70.2 CrH1 FY27 Net Sales: ₹674.1 CrH1 FY27 Net Sales vs FY26 Full Year Revenue: ~57.9%
📅 Short termMarket sentiment is likely to respond positively to the 71% YoY EBITDA growth and strong gross margin resilience despite crude-linked input cost inflation.
📈 Long termThe scaling of non-ADHO portfolio products and network expansion via Project Aarohan (targeting ~60K outlets annually) support long-term revenue diversification.
⚠ Risk flags
- Raw material price inflation in Light Liquid Paraffin (index up to 152) and Copra
- High product concentration in hair oils
Key Highlights
Consolidated Net Sales grew 27.3% YoY to ₹332.7 crore in Q2 FY27
EBITDA increased 71.0% YoY to ₹83.3 crore, with EBITDA margin rising to 25.0% vs 18.6% in Q2 FY26
Consolidated PAT rose 66.0% YoY to ₹70.2 crore
H1 FY27 PAT grew 74.8% YoY to ₹140.9 crore on Net Sales of ₹674.1 crore (+27.8% YoY)
Project Aarohan added 1 Lakh+ retail outlets and 1,100+ distribution partners across three phases
👀 What to Watch
Track whether EBITDA margins sustain near 25% amidst rising raw material cost trends in Light Liquid Paraffin and Copra, and monitor outlet productivity from Aarohan 2.0 in H2 FY27.
Servotech Updates on ₹2.00–₹2.50 Cr Employee Fraud: Two Arrested, ₹75.65 Lakh Recovered
Servotech Renewable Power System provided an update regarding an internal fraud incident initially disclosed on July 23, 2026. The estimated fraud amount remains unchanged at approximately ₹2.00 to ₹2.50 crore, representing about 6-7% of TTM PAT (₹35 crore). Investigating authorities have arrested two employees (Mr. Gagandeep Rajora and Mr. Vijay Kumar) and recovered goods and cheques worth approximately ₹75.65 lakh. The company has appointed an independent forensic auditor to review internal controls and assess the final financial impact.
Confidence: HIGH
What changedTwo employees have been arrested in connection with the suspected internal fraud, and ₹75.65 lakh has been recovered out of the estimated ₹2.00–₹2.50 crore fraud.
Why it mattersWhile the absolute financial exposure (₹2.00–₹2.50 crore) is relatively small compared to TTM revenue of ₹751 crore, it highlights internal control lapses and may result in an earnings provision.
Estimated fraud amount: ₹2.00–₹2.50 croreAmount recovered: Rs.75.65 lakh approx.Fraud vs TTM PAT: ~5.7% to 7.1%Fraud vs TTM revenue: ~0.3%
📅 Short termNegative sentiment regarding governance and internal control mechanisms; potential provision impact in the next quarterly earnings.
📈 Long termLimited direct balance sheet damage given the small quantum, provided forensic audit confirms no deeper systemic fraud or governance breakdown.
⚠ Risk flags
- Internal control failure
- Forensic audit findings could potentially expand the suspected fraud amount
- Unrecovered balance of ~₹1.24–₹1.74 crore
Key Highlights
Estimated fraud amount stands at approximately ₹2.00–₹2.50 crore
Goods and cheques worth approximately ₹75.65 lakh recovered by investigating authorities
Two employees (Gagandeep Rajora and Vijay Kumar) arrested; efforts underway to trace other persons
Independent forensic auditor appointed to review transactions and strengthen internal controls
👀 What to Watch
Track the outcome of the forensic audit report and any write-offs or provisions in upcoming quarterly financial statements.
